ALEVIATIN Side Effects

5842300-4 | Agranulocytosis, Anaemia, Bicytopenia
on Jul 31, 2008 Male patient from JAPAN , weighting 136.7 lb, was diagnosed with epilepsy (What is epilepsy?), gastritis, depression (What is depression?), hypertension, thrombosis prophylaxis, carotid artery stenosis, cerebral infarction, insomnia, benign prostatic hyperplasia and was treated with Aleviatin (View Usage). Patient experienced the following unwanted or unexpected effects: agranulocytosis, anaemia, bicytopenia. Aleviatin dosage: . During the same period patient was treated with FAMOTIDINE (View Famotidine Review and Famotidine Label ), LUVOX (View Luvox Review and Luvox Label ), DIOVAN (View Diovan Review and Diovan Label ), PLAVIX (View Plavix Review and Plavix Label ), MYSLEE (View Myslee Review and Myslee Label ), AVISHOT (View Avishot Review and Avishot Label ). Patient was hospitalized.

5832188-X | Agranulocytosis, Anaemia, Bicytopenia
Patient was taking Aleviatin (View Usage). Patient had the following side effects: agranulocytosis, anaemia, bicytopenia on Jul 24, 2008 from JAPAN Additional patient health information: Male patient , weighting 136.7 lb, was diagnosed with epilepsy (What is epilepsy?), gastritis, depression (What is depression?), hypertension, thrombosis prophylaxis, carotid artery stenosis, cerebral infarction, insomnia, benign prostatic hyperplasia and. Aleviatin dosage: . During the same period patient was treated with FAMOTIDINE (View Famotidine Review and Famotidine Label ), LUVOX (View Luvox Review and Luvox Label ), DIOVAN (View Diovan Review and Diovan Label ), PLAVIX (View Plavix Review and Plavix Label ), MYSLEE (View Myslee Review and Myslee Label ), AVISHOT (View Avishot Review and Avishot Label ). Patient was hospitalized.

5807603-8 | Agranulocytosis, Anaemia, Bicytopenia
Adverse event was reported on Jul 02, 2008 by a Female patient taking Aleviatin (View Usage) (Dosage: ) was diagnosed with epilepsy (What is epilepsy?), gastritis, neurogenic bladder, hypertension, depression (What is depression?), benign prostatic hyperplasia, schizophrenia, myocardial infarction and. Location: JAPAN , weighting 136.7 lb, After Aleviatin was administered, patient had the following side effects: agranulocytosis, anaemia, bicytopenia. During the same period patient was treated with GASTER (View Gaster Review and Gaster Label ), UBRETID (View Ubretid Review and Ubretid Label ), FLUITRAN (View Fluitran Review and Fluitran Label ), LUVOX (View Luvox Review and Luvox Label ), AVISHOT (View Avishot Review and Avishot Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), ADALAT (View Adalat Review and Adalat Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5690960-3 | Leukopenia, Neutropenia
on Mar 21, 2008 Female patient from JAPAN , 55 years of age, weighting 108.0 lb, was diagnosed with epilepsy (What is epilepsy?), colon cancer and was treated with Aleviatin (View Usage). Patient experienced the following unwanted or unexpected effects: leukopenia, neutropenia. Aleviatin dosage: . During the same period patient was treated with ELPLAT (100 Mg/body=69 Mg/m2) (View Elplat Review and Elplat Label ), DEPAKENE (View Depakene Review and Depakene Label ), LEUCOVORIN CALCIUM (235 Mg/body=162.1 Mg/m2) (View Leucovorin Calcium Review and Leucovorin Calcium Label ), FLUOROURACIL (420 Mg/body=289.7 Mg/m2 In Bolus Then 2800 Mg/body=1931 Mg/m2 As Infusion Unk) (View Fluorouracil Review and Fluorouracil Label ), PHENOBAL (View Phenobal Review and Phenobal Label ).


5618926-X | Liver Disorder
on Jan 28, 2008 Female patient from JAPAN , 57 years of age, was treated with Aleviatin (View Usage). Patient had the following side effects: liver disorder. Aleviatin dosage: Unk. During the same period patient was treated with MYSLEE (10 Mg) (View Myslee Review and Myslee Label ).

5393282-3 | Dermatitis Exfoliative, Diarrhoea, Disseminated Intravascular Coagulation, Epilepsy, Erythema, Sepsis, Stevens-johnson Syndrome
Patient was taking Aleviatin (View Usage). After Aleviatin was administered, patient had the following side effects: dermatitis exfoliative, diarrhoea, disseminated intravascular coagulation, epilepsy (What is epilepsy?), erythema, sepsis (What is sepsis?), stevens-johnson syndrome on Jul 20, 2007 from JAPAN Additional patient health information: Female patient , 86 years of age, was diagnosed with epilepsy (What is epilepsy?) and. Aleviatin dosage: . During the same period patient was treated with MYSLEE (View Myslee Review and Myslee Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), TRICHLORMETHIAZIDE (View Trichlormethiazide Review and Trichlormethiazide Label ), DEPAKENE (View Depakene Review and Depakene Label ), TEGRETOL (View Tegretol Review and Tegretol Label ).

5378870-2 | Hepatic Function Abnormal
Adverse event was reported on Jun 26, 2007 by a Male patient taking Aleviatin (View Usage) (Dosage: 200 Mg) was diagnosed with cerebrovascular disorder and. Location: JAPAN , weighting 145.5 lb, Patient experienced the following unwanted or unexpected effects: hepatic function abnormal. During the same period patient was treated with MAGMITT (1800 Mg) (View Magmitt Review and Magmitt Label ), GASTER D (20 Mg) (View Gaster D Review and Gaster D Label ), CLOPIDOGREL (75 Mg) (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

5262693-9 | Depressed Level Of Consciousness
on Mar 01, 2007 Female patient from JAPAN , 16 years of age, was diagnosed with cerebral palsy, haematemesis, dyspepsia, convulsion and was treated with Aleviatin (View Usage). Patient had the following side effects: depressed level of consciousness. Aleviatin dosage: . During the same period patient was treated with LEVOMEPROMAZINE MALEATE (View Levomepromazine Maleate Review and Levomepromazine Maleate Label ), EURODIN (View Eurodin Review and Eurodin Label ), PEPCID (View Pepcid Review and Pepcid Label ), DORMICUM (MIDAZOLAM) (View Dormicum (midazolam) Review and Dormicum (midazolam) Label ), SOLDEM 3A (View Soldem 3a Review and Soldem 3a Label ). Patient was hospitalized.

5142020-8 | Hypospadias
on Oct 20, 2006 Male patient from JAPAN , weighting 6.48 lb, was treated with Aleviatin (View Usage). After Aleviatin was administered, patient had the following side effects: hypospadias. Aleviatin dosage: Maternal Dose 500 Mg/day. During the same period patient was treated with DIAMOX (Maternal Dose 250 Mg/day) (View Diamox Review and Diamox Label ), NITRAZEPAM (Maternal Dose 5 Mg/day) (View Nitrazepam Review and Nitrazepam Label ), TEGRETOL (Maternal Dose 120 Mg/day) (View Tegretol Review and Tegretol Label ).

5054665-4 | Aspartate Aminotransferase Increased, Blood Albumin Decreased, Blood Lactate Dehydrogenase Increased, C-reactive Protein Increased, Cell Marker Increased, Chest X-ray Abnormal, Fibrin D Dimer Increased, Fibrin Degradation Products Increased, Gamma-glutamyltransferase Increased
Patient was taking Aleviatin (View Usage). Patient experienced the following unwanted or unexpected effects: aspartate aminotransferase increased, blood albumin decreased, blood lactate dehydrogenase increased, c-reactive protein increased, cell marker increased, chest x-ray abnormal, fibrin d dimer increased, fibrin degradation products increased, gamma-glutamyltransferase increased on Jun 09, 2006 from JAPAN Additional patient health information: Male patient , 71 years of age, weighting 132.3 lb, was diagnosed with convulsion, constipation (What is constipation?) and. Aleviatin dosage: 250 Mg/day. During the same period patient was treated with MAGNESIUM OXIDE (1.5 G/day) (View Magnesium Oxide Review and Magnesium Oxide Label ), LAC B (3 G/day) (View Lac B Review and Lac B Label ), TEGRETOL (300 Mg/day) (View Tegretol Review and Tegretol Label ).

4982995-0 | C-reactive Protein Increased, Decreased Activity, Hypothermia, Platelet Count Decreased, Urinary Tract Infection, White Blood Cell Count Increased
Adverse event was reported on Mar 09, 2006 by a Male patient taking Aleviatin (View Usage) (Dosage: ) was diagnosed with epilepsy (What is epilepsy?), musculoskeletal stiffness and. Location: JAPAN , 39 years of age, Patient had the following side effects: c-reactive protein increased, decreased activity, hypothermia (What is hypothermia?), platelet count decreased, urinary tract infection (What is urinary tract infection?), white blood cell count increased. During the same period patient was treated with PRIMIDONE (View Primidone Review and Primidone Label ), DEPAKENE (View Depakene Review and Depakene Label ), LIORESAL (5 Mg, Qd) (View Lioresal Review and Lioresal Label ).

4964378-2 | C-reactive Protein Increased, Decreased Activity, Hypothermia, Platelet Count Decreased, Urinary Tract Infection, White Blood Cell Count Increased
on Mar 09, 2006 Male patient from JAPAN , 39 years of age, was diagnosed with epilepsy (What is epilepsy?), musculoskeletal stiffness and was treated with Aleviatin (View Usage). After Aleviatin was administered, patient had the following side effects: c-reactive protein increased, decreased activity, hypothermia (What is hypothermia?), platelet count decreased, urinary tract infection (What is urinary tract infection?), white blood cell count increased. Aleviatin dosage: . During the same period patient was treated with PRIMIDONE (View Primidone Review and Primidone Label ), DEPAKENE (View Depakene Review and Depakene Label ), LIORESAL (5 Mg, Qd) (View Lioresal Review and Lioresal Label ).

4845039-7 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Pressure Decreased, Candidiasis, Cerebral Infarction, Depressed Level Of Consciousness, Dysphagia, Eating Disorder, Gamma-glutamyltransferase Increased
on Oct 26, 2005 Male patient from JAPAN , 71 years of age, was diagnosed with convulsion, pneumonia (What is pneumonia?), prophylaxis, pneumonia staphylococcal, cerebral infarction and was treated with Aleviatin (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood pressure decreased, candidiasis, cerebral infarction, depressed level of consciousness, dysphagia, eating disorder (What is eating disorder?), gamma-glutamyltransferase increased. Aleviatin dosage: . During the same period patient was treated with MODACIN (View Modacin Review and Modacin Label ), OMEPRAL (View Omepral Review and Omepral Label ), PEPCID (View Pepcid Review and Pepcid Label ), TARGOCID (View Targocid Review and Targocid Label ), RADICUT (View Radicut Review and Radicut Label ). Patient was hospitalized.

4673265-9 | Epilepsy
Patient was taking Aleviatin (View Usage). Patient had the following side effects: epilepsy (What is epilepsy?) on Mar 03, 2005 from Additional patient health information: Male patient , 21 years of age, was diagnosed with epilepsy (What is epilepsy?), urticaria and. Aleviatin dosage: . During the same period patient was treated with PHENOBARBITAL (View Phenobarbital Review and Phenobarbital Label ), ZADITEN (2 Mg/day) (View Zaditen Review and Zaditen Label ).

4604911-3 | Epilepsy
Adverse event was reported on Mar 03, 2005 by a Male patient taking Aleviatin (View Usage) (Dosage: ) was diagnosed with epilepsy (What is epilepsy?) and. Location: , 21 years of age, After Aleviatin was administered, patient had the following side effects: epilepsy (What is epilepsy?). During the same period patient was treated with PHENOBARBITAL (View Phenobarbital Review and Phenobarbital Label ), ZADITEN (View Zaditen Review and Zaditen Label ).